HYDROXYPROGESTERONE-17

Radioimmunoassay, Progesterone

DIAGNOSTICS BIOCHEM CANADA, INC.

The following data is part of a premarket notification filed by Diagnostics Biochem Canada, Inc. with the FDA for Hydroxyprogesterone-17.

Pre-market Notification Details

Device IDK832297
510k NumberK832297
Device Name:HYDROXYPROGESTERONE-17
ClassificationRadioimmunoassay, Progesterone
Applicant DIAGNOSTICS BIOCHEM CANADA, INC. 803 N. Front St. Suite 3 Mchenry,  IL  60050
Product CodeJLS  
CFR Regulation Number862.1620 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1983-07-13
Decision Date1983-09-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.